Transaction #33850 · Form 4 · 0001809519-26-000173
GoodRx Holdings, Inc. · Exercise / conversion · Class A Common Stock
GoodRx Holdings, Inc. · Transacted October 15, 2026 · Filed October 15, 2026
What does this filing report?
An SEC Form 4 filing for GoodRx Holdings, Inc. records an exercise / conversion involving Class A Common Stock on October 15, 2026. The reported quantity was 51,177. The filing date is October 15, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- GoodRx Holdings, Inc.
- Company CIK
- 0001809519
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 51,177
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 857,962
- Ownership description
- Not reported
- SEC acceptance time
- Oct 15, 2026, 4:20 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Barnes Wendy Lynn ↗
See Remarks · Director
CIK 0002049585
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- F2
- The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.
- F3
- The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters.
- F4
- The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date.
Remarks
Chief Executive Officer and President
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.